Regarding recent investigations into the immunology of SARS-CoV-2 infection, lower percentages of CD3+CD56+ (NKT-like) cells have been observed in COVID-19 subjects when compared to healthy controls. This evidence concerns the gene NCAM1 and COVID-19.